Cough, hemoptysis, and weight loss: Difference between revisions

Jump to navigation Jump to search
Anmol Pitliya (talk | contribs)
Created page with "__NOTOC__ {{CMG}}; {{AE}} {{KZ}}, {{Anmol}} ==Cough, Hemoptysis, and Weight Loss differential diagnosis== {| ! colspan="2" rowspan="3" align="center" style="background:#4479..."
 
Anmol Pitliya (talk | contribs)
No edit summary
 
Line 4: Line 4:


==Cough, Hemoptysis, and Weight Loss differential diagnosis==
==Cough, Hemoptysis, and Weight Loss differential diagnosis==
{|
{|
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
|-
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
|-
Line 27: Line 28:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
|-
| align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']]
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']]
| align="center" style="background:#DCDCDC;" + |[[Upper respiratory tract|'''Upper airway diseases''']]
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Parenchyma|'''Parenchyma''']]
| align="center" style="background:#DCDCDC;" + |[[Pertussis|'''Pertussis''']]<ref name="pmid3816065">{{cite journal |vauthors=Bellamy EA, Johnston ID, Wilson AG |title=The chest radiograph in whooping cough |journal=Clin Radiol |volume=38 |issue=1 |pages=39–43 |year=1987 |pmid=3816065 |doi= |url=}}</ref><ref name="urlPertussis | Whooping Cough | Clinical | Information | CDC">{{cite web |url=https://www.cdc.gov/pertussis/clinical/index.html |title=Pertussis &#124; Whooping Cough &#124; Clinical &#124; Information &#124; CDC |format= |work= |accessdate=}}</ref>
| align="center" style="background:#F5F5F5;" + |Acute
| style="background:#F5F5F5;" + |
*Two weeks
| align="center" style="background:#F5F5F5;" + | + Whooping sound
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*Clear chest
| style="background:#F5F5F5;" + |
*[[Polymerase chain reaction|Polymerase chain reactio]]<nowiki/>n ([[Polymerase chain reaction|PCR]]) shows ''[[Bordetella pertussis]]''
*Serologic testing
| style="background:#F5F5F5;" + |
*[[Atelectasis]] may seen on chest imaging
*[[Lymphadenopathy]]
| style="background:#F5F5F5;" + |
*Normal function
| style="background:#F5F5F5;" + |
*Culture
| style="background:#F5F5F5;" + |
*Etiology: ''[[Bordetella pertussis]]''
*Phases: Catarrhal, paroxysmal and convalescent
|-
| rowspan="5" align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']]
| rowspan="5" align="center" style="background:#DCDCDC;" + |[[Parenchyma|'''Parenchyma''']]
| align="center" style="background:#DCDCDC;" + |[[Pneumoconiosis|'''Pneumoconioses''']]<ref name="pmid27980247">{{cite journal |vauthors=Jp NA, Imanaka M, Suganuma N |title=Japanese workplace health management in pneumoconiosis prevention |journal=J Occup Health |volume=59 |issue=2 |pages=91–103 |year=2017 |pmid=27980247 |pmc=5478517 |doi=10.1539/joh.16-0031-RA |url=}}</ref><ref name="pmid12668748">{{cite journal |vauthors=Weiland DA, Lynch DA, Jensen SP, Newell JD, Miller DE, Crausman RS, Kuhn C, Kern DG |title=Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease |journal=Radiology |volume=227 |issue=1 |pages=222–31 |year=2003 |pmid=12668748 |doi=10.1148/radiol.2271011063 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Acute, Chronic
| style="background:#F5F5F5;" + |
*Years
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Rhonchi]]
*[[Rales|Crackles]]
| style="background:#F5F5F5;" + |
*[[CBC]] and [[ABG]] may be helpful
| style="background:#F5F5F5;" + |
*Small oppacities and [[fibrosis]] observed in [[Chest X-ray|chest X−ray]]
*[[Computed tomography|CT]] and [[Positron emission tomography|FDG−PET]] may be helpful
| style="background:#F5F5F5;" + |
*[[FEV1/FVC ratio|FEV1/FVC]] <70%
*[[FEV1]] <80%
| style="background:#F5F5F5;" + |
*Exposure history  and [[Chest X-ray|chest radiograph]]
| style="background:#F5F5F5;" + |
*Fibrogenic: [[Silica]], [[asbestos]]
*Inert: [[Iron]], [[barium]]
*Granulomatous: [[Beryllium]]
*Giant cell pneumonia: [[Cobalt]]
|-
| align="center" style="background:#DCDCDC;" + |[[Lung cancer|'''Lung cancer''']]<ref name="pmid21296855">{{cite journal |vauthors=Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D |title=Global cancer statistics |journal=CA Cancer J Clin |volume=61 |issue=2 |pages=69–90 |year=2011 |pmid=21296855 |doi=10.3322/caac.20107 |url=}}</ref><ref name="pmid23649435">{{cite journal |vauthors=Ost DE, Jim Yeung SC, Tanoue LT, Gould MK |title=Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |journal=Chest |volume=143 |issue=5 Suppl |pages=e121S–e141S |year=2013 |pmid=23649435 |pmc=4694609 |doi=10.1378/chest.12-2352 |url=}}</ref>
| align="center" style="background:#DCDCDC;" + |[[Lung cancer|'''Lung cancer''']]<ref name="pmid21296855">{{cite journal |vauthors=Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D |title=Global cancer statistics |journal=CA Cancer J Clin |volume=61 |issue=2 |pages=69–90 |year=2011 |pmid=21296855 |doi=10.3322/caac.20107 |url=}}</ref><ref name="pmid23649435">{{cite journal |vauthors=Ost DE, Jim Yeung SC, Tanoue LT, Gould MK |title=Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |journal=Chest |volume=143 |issue=5 Suppl |pages=e121S–e141S |year=2013 |pmid=23649435 |pmc=4694609 |doi=10.1378/chest.12-2352 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| align="center" style="background:#F5F5F5;" + |Chronic
Line 179: Line 124:
*Complications: [[Pneumothorax]], [[bronchiectasis]], pulmonary destruction and [[chronic pulmonary aspergillosis]]
*Complications: [[Pneumothorax]], [[bronchiectasis]], pulmonary destruction and [[chronic pulmonary aspergillosis]]
|-
|-
| align="center" style="background:#DCDCDC;" + |[[Cystic fibrosis|'''Cystic fibrosis''']]  ([[Cystic fibrosis|CF]])<ref name="pmid18639722">{{cite journal |vauthors=Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW |title=Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report |journal=J. Pediatr. |volume=153 |issue=2 |pages=S4–S14 |year=2008 |pmid=18639722 |pmc=2810958 |doi=10.1016/j.jpeds.2008.05.005 |url=}}</ref><ref name="pmid1285737">{{cite journal |vauthors=Kerem E, Reisman J, Corey M, Canny GJ, Levison H |title=Prediction of mortality in patients with cystic fibrosis |journal=N. Engl. J. Med. |volume=326 |issue=18 |pages=1187–91 |year=1992 |pmid=1285737 |doi=10.1056/NEJM199204303261804 |url=}}</ref>
| colspan="2" align="center" style="background:#DCDCDC;" + |[[Heart|'''Cardiac''']]
| align="center" style="background:#F5F5F5;" + |Chronic
| align="center" style="background:#F5F5F5;" + |
*Variable
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +/−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*Barrel−shaped chest
*[[Wheezing]]
*[[Tachypnea]]
| style="background:#F5F5F5;" + |
*[[Respiratory tract]] [[Culture media|culture]] may be helpful for diagnosing secondary bacterial infection
*[[Bronchoalveolar lavage]] for cytology may be helpful
*≥ 60 mmol/L [[Sweat chloride test]]
*[[CFTR (gene)|CFTR]] [[mutation]] in molecular testing may be positive
| style="background:#F5F5F5;" + |
*Hyperinflation, [[atelectasis]], and infiltrates on [[Chest X-ray|chest X−Ray]]
*Severe patients present bronchietasis, "tram tracks" [[Peribronchial cuffing|peribronchial cuffin]]<nowiki/>g in [[Chest X-ray|chest X−Ray]]
*The extension of [[bronchietasis]] can be defined by [[Computed tomography|CT]]
| style="background:#F5F5F5;" + |
*[[Residual volume|RV]]/[[Total lung capacity|TLC]] ratio increased
*[[FEV1/FVC ratio]] <70%
*Low levels of [[FEV1]]
*High levels of [[Total lung capacity|TLC]]
*[[Residual volume|RV]] increased
| style="background:#F5F5F5;" + |
*[[Sweat chloride test]]
| style="background:#F5F5F5;" + |
*Evidence of [[Cystic fibrosis transmembrane conductance regulator|CFTR]] dysfunction
|-
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive cough
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight lost
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PFT
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
| colspan="2" rowspan="2" align="center" style="background:#DCDCDC;" + |[[Heart|'''Cardiac''']]
| align="center" style="background:#DCDCDC;" + |[[Pulmonary edema|'''Cardiogenic pulmonary edema''']]<ref name="pmid16365214">{{cite journal |vauthors=Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L |title=Acute heart failure syndromes: current state and framework for future research |journal=Circulation |volume=112 |issue=25 |pages=3958–68 |year=2005 |pmid=16365214 |doi=10.1161/CIRCULATIONAHA.105.590091 |url=}}</ref><ref name="pmid23741058">{{cite journal |vauthors=Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL |title=2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines |journal=Circulation |volume=128 |issue=16 |pages=e240–327 |year=2013 |pmid=23741058 |doi=10.1161/CIR.0b013e31829e8776 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Acute
| style="background:#F5F5F5;" + |
*Days to weeks
| align="center" style="background:#F5F5F5;" + | + Pink frothy, liquid
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Rales|Crackles]]
*Increased [[respiratory rate]]
*[[Wheeze|Wheezing]]
*[[Rhonchi]]
*Gurgling sounds
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Arterial blood gas]]
*[[Blood urea nitrogen|BUN]]
*[[Serum creatinine|Serum creatinin]]
*Serum [[troponin]]
*[[Electrolyte|Electrolytes]]
*[[Lactic acid]]
*[[Complete blood count]]
| style="background:#F5F5F5;" + |
*[[Cardiomegaly]], [[pleural effusion]], interstitial [[edema]], alveolar [[edema]] and blood redistribution in lower lobes in [[Chest X-ray|chest X−ray]]
| style="background:#F5F5F5;" + |
*Not specific
| style="background:#F5F5F5;" + |
*Clinical diagnosis
*Tests are supportive
| style="background:#F5F5F5;" + |
*[[12-lead ECG|12−lead ECG]]
*Plasma [[Brain natriuretic peptide|BNP]] and [[NT-proBNP|NT−proBNP]]
*[[Echocardiography]]
|-
| align="center" style="background:#DCDCDC;" + |[[Pulmonary hypertension|'''Pulmonary hypertension''']]<ref name="pmid21393391">{{cite journal |vauthors=Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG |title=Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry |journal=Chest |volume=140 |issue=1 |pages=19–26 |year=2011 |pmid=21393391 |pmc=3198486 |doi=10.1378/chest.10-1166 |url=}}</ref><ref name="pmid12651053">{{cite journal| author=Sun XG, Hansen JE, Oudiz RJ, Wasserman K| title=Pulmonary function in primary pulmonary hypertension. | journal=J Am Coll Cardiol | year= 2003 | volume= 41 | issue= 6 | pages= 1028-35 | pmid=12651053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12651053  }}</ref>
| align="center" style="background:#DCDCDC;" + |[[Pulmonary hypertension|'''Pulmonary hypertension''']]<ref name="pmid21393391">{{cite journal |vauthors=Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG |title=Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry |journal=Chest |volume=140 |issue=1 |pages=19–26 |year=2011 |pmid=21393391 |pmc=3198486 |doi=10.1378/chest.10-1166 |url=}}</ref><ref name="pmid12651053">{{cite journal| author=Sun XG, Hansen JE, Oudiz RJ, Wasserman K| title=Pulmonary function in primary pulmonary hypertension. | journal=J Am Coll Cardiol | year= 2003 | volume= 41 | issue= 6 | pages= 1028-35 | pmid=12651053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12651053  }}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| align="center" style="background:#F5F5F5;" + |Chronic
Line 301: Line 156:
*Peripherial [[edema]]
*Peripherial [[edema]]
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" + |[[Gastrointestinal tract|'''Gastrointestinal''']]
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" colspan="2" + |Organ system
| align="center" style="background:#DCDCDC;" + |[[Gastroesophageal reflux disease|'''Gastroesophageal reflux''']]<ref name="pmid21508423">{{cite journal |vauthors=Kahrilas PJ, Hughes N, Howden CW |title=Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease |journal=Gut |volume=60 |issue=11 |pages=1473–8 |year=2011 |pmid=21508423 |doi=10.1136/gut.2011.241307 |url=}}</ref><ref name="pmid25133039">{{cite journal| author=Badillo R, Francis D| title=Diagnosis and treatment of gastroesophageal reflux disease. | journal=World J Gastrointest Pharmacol Ther | year= 2014 | volume= 5 | issue= 3 | pages= 105-12 | pmid=25133039 | doi=10.4292/wjgpt.v5.i3.105 | pmc=4133436 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25133039  }}</ref>
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Diseases
| align="center" style="background:#F5F5F5;" + |Chronic
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="8" + |Clinical manifestations
| style="background:#F5F5F5;" + |
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="2" colspan="4" + |Diagnosis
*Variable
! align="center" style="background:#4479BA; color: #FFFFFF;" rowspan="3" + |Other features
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*[[Hoarseness]]
| style="background:#F5F5F5;" + |
*Not specific
| style="background:#F5F5F5;" + |
*[[Upper endoscopy]] may be helpful
*[[Barium]] esophagram may be helpful
| style="background:#F5F5F5;" + |
*Normal function
| style="background:#F5F5F5;" + |
*PH testing
| align="center" style="background:#F5F5F5;" + |−−
|-
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features
|-
|-
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" colspan="7" + |Symptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam
|-
|-
Line 347: Line 178:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard
|-
|-
| colspan="2" rowspan="4" align="center" style="background:#DCDCDC;" + |'''[[Autoimmune]]'''
| align="center" style="background:#DCDCDC;" rowspan="3" colspan="2" + |'''[[Autoimmune]]'''
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref>
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| align="center" style="background:#F5F5F5;" + |Chronic
Line 381: Line 212:
*[[Saddle nose|Saddle nose deformity]]
*[[Saddle nose|Saddle nose deformity]]
*[[Purpura]] in lower extremities
*[[Purpura]] in lower extremities
|-
| align="center" style="background:#DCDCDC;" + |[[Sarcoidosis|'''Sarcoidosis''']]<ref name="pmid27378039">{{cite journal |vauthors=Carmona EM, Kalra S, Ryu JH |title=Pulmonary Sarcoidosis: Diagnosis and Treatment |journal=Mayo Clin. Proc. |volume=91 |issue=7 |pages=946–54 |year=2016 |pmid=27378039 |doi=10.1016/j.mayocp.2016.03.004 |url=}}</ref><ref name="pmid12803116">{{cite journal |vauthors=Yanardağ H, Pamuk GE, Karayel T, Demirci S |title=Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples |journal=Haematologia (Budap) |volume=32 |issue=4 |pages=419–25 |year=2002 |pmid=12803116 |doi= |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |Chronic
| style="background:#F5F5F5;" + |
*Years
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| style="background:#F5F5F5;" + |
*[[Wheeze|Wheezing]]
*Squeaky sounds
| style="background:#F5F5F5;" + |The following investigations may be helpful:
*[[Complete blood count]] ([[CBC]])
*[[Urinalysis]]
*[[Blood urea nitrogen|BUN]]
*[[Liver function tests|Liver function test]]
*[[Calcium]]
*[[Alkaline phosphatase]] levels
*[[Electrolyte|Electrolytes]]
*[[Histopathology|Histopathologic]] detection
| style="background:#F5F5F5;" + |
*On [[Chest X-ray|chest X−Ray]]:
**Stage 1: Bilateral hiliar [[adenopathy]]
**Stage 2: [[Reticular]] opacities and hiliar adenopathy
**Stage 3: Shrink hiliar [[Nodule (medicine)|nodules]] and [[reticular]] opacities
**Stage 4: Lost of volume
| style="background:#F5F5F5;" + |
*Reduced [[FVC]]
*Decreased of [[Total lung capacity|TLC]]
| style="background:#F5F5F5;" + |
*Clinical diagnosis, [[Histopathology|histopathologic]] detection of noncaseating [[Granuloma|granulomas]] and exclusion of other diseases
| style="background:#F5F5F5;" + |
*Young adults
*[[Skin]], [[joint]] and [[eye]] lesions
|-
|-
| align="center" style="background:#DCDCDC;" + |'''Microscopic polyangitis ([[Microscopic polyangiitis|MPA]])'''<ref name="JennetteFalk1997">{{cite journal|last1=Jennette|first1=J. Charles|last2=Falk|first2=Ronald J.|title=Small-Vessel Vasculitis|journal=New England Journal of Medicine|volume=337|issue=21|year=1997|pages=1512–1523|issn=0028-4793|doi=10.1056/NEJM199711203372106}}</ref>
| align="center" style="background:#DCDCDC;" + |'''Microscopic polyangitis ([[Microscopic polyangiitis|MPA]])'''<ref name="JennetteFalk1997">{{cite journal|last1=Jennette|first1=J. Charles|last2=Falk|first2=Ronald J.|title=Small-Vessel Vasculitis|journal=New England Journal of Medicine|volume=337|issue=21|year=1997|pages=1512–1523|issn=0028-4793|doi=10.1056/NEJM199711203372106}}</ref>

Latest revision as of 23:00, 10 March 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Karina Zavaleta, MD [2], Anmol Pitliya, M.B.B.S. M.D.[3]

Cough, Hemoptysis, and Weight Loss differential diagnosis

Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Respiratory Parenchyma Lung cancer[1][2] Chronic
  • Years
+ + + +/− + The following investigations may be helpful:
  • Not specific
Interstitial lung disease[3][4] Chronic
  • Variable
+ + + The following investigations may be helpful:
  • Lung biopsy when lab, imaging, and PFT has indeterminate result
Tuberculosis (TB)[5][6] Chronic
  • More than 2 or 3 weeks
+ + + + +
Cardiac Pulmonary hypertension[7][8] Chronic
  • More than 2 years
+ + + The following investigations may be helpful:
Organ system Diseases Clinical manifestations Diagnosis Other features
Symptoms Physical exam
Onset Duration Productive cough Hemoptysis Weight lost Fever Dyspnea Ascultation Lab findings Imaging PFT Gold standard
Autoimmune Wegener's disease (GPA) [9][10] Chronic
  • Months
+ + + + + The following investigations may be helpful:
Microscopic polyangitis (MPA)[11] Chronic
  • Variable
+ + + + + The following investigations may be helpful:
Churg−Strauss[12][13] Chronic
  • Variable
+ + + + +
  • Infiltrates in chest X−Ray
  • Ground glass opacities, tree−in−bud sign and small nodules in chest CT

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". CA Cancer J Clin. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855.
  2. Ost DE, Jim Yeung SC, Tanoue LT, Gould MK (2013). "Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e121S–e141S. doi:10.1378/chest.12-2352. PMC 4694609. PMID 23649435.
  3. Lama VN, Martinez FJ (2004). "Resting and exercise physiology in interstitial lung diseases". Clin. Chest Med. 25 (3): 435–53, v. doi:10.1016/j.ccm.2004.05.005. PMID 15331185.
  4. Chetta A, Marangio E, Olivieri D (2004). "Pulmonary function testing in interstitial lung diseases". Respiration. 71 (3): 209–13. doi:10.1159/000077416. PMID 15133338.
  5. Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R (1997). "Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)". Clin. Infect. Dis. 25 (2): 242–6. PMID 9332519.
  6. Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988). "Chest roentgenogram in pulmonary tuberculosis. New data on an old test". Chest. 94 (2): 316–20. PMID 2456183.
  7. Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG (2011). "Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry". Chest. 140 (1): 19–26. doi:10.1378/chest.10-1166. PMC 3198486. PMID 21393391.
  8. Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2003). "Pulmonary function in primary pulmonary hypertension". J Am Coll Cardiol. 41 (6): 1028–35. PMID 12651053.
  9. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992). "Wegener granulomatosis: an analysis of 158 patients". Ann. Intern. Med. 116 (6): 488–98. PMID 1739240.
  10. Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
  11. Jennette, J. Charles; Falk, Ronald J. (1997). "Small-Vessel Vasculitis". New England Journal of Medicine. 337 (21): 1512–1523. doi:10.1056/NEJM199711203372106. ISSN 0028-4793.
  12. Vaglio A, Buzio C, Zwerina J (2013). "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art". Allergy. 68 (3): 261–73. doi:10.1111/all.12088. PMID 23330816.
  13. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.